Get the Stockscreener App
3.96
0.75%
-0.04
Mural Oncology Plc Stock (MURA) Forecast
The Mural Oncology Plc (MURA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.8724, representing a -77.97% decrease from the current price of $3.96. The highest analyst price target is $1.2148, and the lowest is $0.53.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MURA Price Target
Average 2.3043
(-41.81% Downside)
Is Mural Oncology Plc (MURA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 66.07 | Neutral |
| STOCH(9,6) | 71.28 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.0747 | Buy |
| ADX(14) | 27.47 | Buy |
| William %R | -8.6538 | Sell |
| CCI(14) | 98.47 | Neutral |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.671
Buy
|
3.6807
Buy
|
| MA20 |
3.436
Buy
|
3.5929
Buy
|
| MA50 |
3.5752
Buy
|
3.5488
Buy
|
| MA100 |
3.4608
Buy
|
3.5357
Buy
|
| MA200 |
3.4829
Buy
|
3.73
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, MURA could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 2 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on MURA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 66.07 indicates that MURA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 71.28 indicates that MURA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that MURA is oversold. This suggests that MURA price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 27.47 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 98.47 indicates that MURA is still overbought but not to an extreme extent.
Long-term MURA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Mural Oncology Plc financial reports and earnings history, Mural Oncology Plc (MURA) stock could reach $23.56 by 2030, $72.49 by 2040 and $88.35 by 2050. See the projected annual prices until 2050 of the Mural Oncology Plc stock below:
- Mural Oncology Plc (MURA) is expected to reach an average price of $35.98 in 2035, with a high prediction of $38.82 and a low estimate of $36.57. This indicates an $808.67% rise from the last recorded price of $3.96.
- Mural Oncology Plc (MURA) stock is projected to chart a bullish course in 2040, with an average price target of $72.39, representing an $1,728% surge from its current level. The forecast ranges from a conservative $47.91 to a sky-high $72.49.
- Our analysts predict Mural Oncology Plc (MURA) to jump 1,919% by 2045, soaring from $80.11 to an average price of $79.96, potentially reaching $85.12. While $80.11 is the low estimate, the potential upside is significant.
- Mural Oncology Plc (MURA) stock is expected to climb by 2050, reaching an average of $82.99, a $1,996% jump from its current level. However, a wide range of estimates exists, with high and low targets of $88.35 and $83.11, respectively, highlighting the market's uncertainty.
Mural Oncology Plc Stock (MURA) Year by Year Forecast
Mural Oncology Plc Stock (MURA) Price Forecast for 2025
Mural Oncology Plc Stock (MURA) is expected to reach an average price of $2.3043 in 2025, with a high prediction of $4.6013 and a low estimate of $0.00732. This indicates an -41.81% fall from the last recorded price of $3.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2025 | $0.14 | $0.53 | $1.2148 | -96.46% |
| March, 2025 | $1.1076 | $1.0594 | $0.8088 | -72.03% |
| April, 2025 | $0.2705 | $0.5195 | $0.802 | -93.17% |
| May, 2025 | $0.1271 | $0.00732 | $0.7947 | -96.79% |
| June, 2025 | $0.6846 | $0.1909 | $0.5784 | -82.71% |
| July, 2025 | $2.9725 | $0.2978 | $1.93 | -24.94% |
| August, 2025 | $2.7026 | $2.9326 | $2.705 | -31.75% |
| September, 2025 | $1.4027 | $2.1927 | $2.4851 | -64.58% |
| October, 2025 | $1.1653 | $1.2577 | $1.2678 | -70.57% |
| November, 2025 | $1.9654 | $1.6728 | $1.8254 | -50.37% |
| December, 2025 | $5.3013 | $1.6204 | $4.6013 | +33.87% |
Mural Oncology Plc Stock (MURA) Price Forecast for 2026
The predicted value for Mural Oncology Plc (MURA) in 2026 is set at an average of $5.6305. Estimates vary from a peak of $8.3938 to a trough of $2.8672, indicating an +42.18% surge from the present price of $3.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.3239 | $4.6539 | $4.462 | +9.19% |
| February, 2026 | $2.8165 | $2.9665 | $3.4846 | -28.88% |
| March, 2026 | $2.6791 | $2.8672 | $2.8135 | -32.35% |
| April, 2026 | $3.0724 | $3.1548 | $3.2117 | -22.42% |
| May, 2026 | $7.1976 | $2.943 | $6.4976 | +81.76% |
| June, 2026 | $6.0927 | $6.4227 | $6.3263 | +53.86% |
| July, 2026 | $4.2566 | $4.4766 | $5.2215 | +7.49% |
| August, 2026 | $4.5617 | $4.6367 | $4.3591 | +15.19% |
| September, 2026 | $4.4318 | $4.2656 | $4.598 | +11.91% |
| October, 2026 | $8.3407 | $8.37 | $8.3938 | +110.62% |
| November, 2026 | $7.2284 | $7.7784 | $8.0046 | +82.53% |
| December, 2026 | $6.2329 | $6.086 | $6.8728 | +57.40% |
Mural Oncology Plc Stock (MURA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Mural Oncology Plc (MURA) is $9.6391, with a high forecast of $13.69 and a low forecast of $5.5882. This indicates an +143.41% increase from the last price of $3.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.9306 | $6.1187 | $5.9048 | +49.76% |
| February, 2027 | $5.7863 | $5.5882 | $5.9844 | +46.12% |
| March, 2027 | $10.27 | $10.30 | $10.29 | +159.35% |
| April, 2027 | $8.9103 | $9.1403 | $9.8052 | +125.01% |
| May, 2027 | $7.8105 | $7.6954 | $7.8654 | +97.23% |
| June, 2027 | $7.7757 | $7.5807 | $7.4505 | +96.36% |
| July, 2027 | $11.90 | $6.9108 | $11.73 | +200.51% |
| August, 2027 | $12.10 | $12.13 | $12.19 | +205.62% |
| September, 2027 | $9.7685 | $10.56 | $11.61 | +146.68% |
| October, 2027 | $9.4012 | $9.3049 | $9.2717 | +137.40% |
| November, 2027 | $9.1939 | $9.0307 | $8.5907 | +132.17% |
| December, 2027 | $14.54 | $8.2334 | $13.69 | +267.20% |
Mural Oncology Plc Stock (MURA) Price Forecast for 2028
In 2028, Mural Oncology Plc (MURA) is projected to reach an average price of $13.72, with a high projection of $17.88 and a low estimate of $9.556. This indicates an +246.35% rise from the last price of $3.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $13.51 | $13.74 | $14.08 | +241.07% |
| February, 2028 | $11.44 | $12.23 | $13.10 | +188.93% |
| March, 2028 | $10.25 | $10.84 | $10.91 | +158.79% |
| April, 2028 | $10.28 | $10.42 | $10.14 | +159.68% |
| May, 2028 | $16.68 | $9.556 | $15.98 | +321.18% |
| June, 2028 | $14.94 | $15.27 | $15.65 | +277.19% |
| July, 2028 | $12.66 | $12.81 | $13.91 | +219.81% |
| August, 2028 | $11.97 | $12.05 | $12.09 | +202.31% |
| September, 2028 | $11.20 | $11.32 | $11.53 | +182.81% |
| October, 2028 | $18.58 | $10.88 | $17.88 | +369.07% |
| November, 2028 | $15.91 | $16.46 | $17.51 | +301.84% |
| December, 2028 | $13.91 | $14.13 | $15.40 | +251.34% |
Mural Oncology Plc Stock (MURA) Price Forecast for 2029
The 2029 price forecast for Mural Oncology Plc Stock (MURA) is $17.85 on average, with a high prediction of $23.49 and a low estimate of $12.20. This represents an +350.65% increase from the previous price of $3.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $13.18 | $13.38 | $13.63 | +232.85% |
| February, 2029 | $12.56 | $12.20 | $12.92 | +217.14% |
| March, 2029 | $19.53 | $20.08 | $19.77 | +393.11% |
| April, 2029 | $17.65 | $18.20 | $18.97 | +345.70% |
| May, 2029 | $15.70 | $15.74 | $17.10 | +296.42% |
| June, 2029 | $14.63 | $14.83 | $15.18 | +269.47% |
| July, 2029 | $13.91 | $13.52 | $14.30 | +251.34% |
| August, 2029 | $21.27 | $21.30 | $21.67 | +437.00% |
| September, 2029 | $19.14 | $19.37 | $20.61 | +383.35% |
| October, 2029 | $17.13 | $17.35 | $17.90 | +332.57% |
| November, 2029 | $16.28 | $16.28 | $16.07 | +311.24% |
| December, 2029 | $23.66 | $14.85 | $23.49 | +497.47% |
Mural Oncology Plc Stock (MURA) Price Forecast for 2030
Mural Oncology Plc Stock (MURA) is expected to reach an average price of $21.79 in 2030, with a high forecast of $27.41 and a low forecast of $16.17. This signifies an +450.24% surge from the last price of $3.96.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $22.51 | $22.74 | $23.56 | +468.43% |
| February, 2030 | $19.81 | $20.60 | $21.94 | +400.19% |
| March, 2030 | $18.68 | $18.92 | $19.12 | +371.60% |
| April, 2030 | $17.70 | $17.73 | $17.59 | +347.05% |
| May, 2030 | $26.11 | $16.17 | $25.45 | +559.35% |
| June, 2030 | $24.31 | $24.54 | $25.46 | +513.90% |
| July, 2030 | $20.87 | $21.02 | $23.71 | +427.04% |
| August, 2030 | $19.33 | $19.92 | $20.13 | +388.16% |
| September, 2030 | $18.60 | $18.74 | $18.74 | +369.73% |
| October, 2030 | $28.06 | $17.49 | $27.41 | +608.50% |
| November, 2030 | $25.55 | $25.88 | $26.83 | +545.18% |
| December, 2030 | $22.51 | $22.66 | $24.33 | +468.49% |
0.11%
0.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):